Outset Medical is a medical technology company. The Tablo® Hemodialysis System (Tablo) is cleared by the U.S. Food and Drug Administration for use from the hospital to the home. Tablo is designed to be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. The integration of water purification and dialysate production in a compact console enables Tablo to serve as a dialysis clinic on wheels. With a touchscreen interface, two-way wireless data transmission and a proprietary data analytics platform, Tablo is an approach to dialysis care. The Tablo system includes Tablo Console, Tablo Cartridge and Tablo Data Ecosystem components. The OM YTD return is shown above.
The YTD Return on the OM YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether OM YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the OM YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|